Tamoxifen Active Not Recruiting Phase 2 Trials for Mammographic Density Reduction / Risk Reduction Prevention

IndicationsStatusPurposePhase
Active Not RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT03346200Karma Intervention Study